Skip to content

Insider · CIK 0001303521

Alan Fuhrman

cfoofficerdirector

Files at SWTX (SpringWorks Therapeutics, Inc.), TYRA (Tyra Biosciences, Inc.). First filing Nov 1, 2024, latest Nov 1, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$152k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TYRA: Tyra Biosciences, Inc.

TYRAOct 9, 2026 · close 19.94

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
51Moderate
TYRAbuy 2
Tyra Biosciences, Inc.
$152k
9,500 shares
+284%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 15, 2026TYRA
Tyra Biosciences, Inc.
AGrant or award
Common Stock
+951$9.13$8,68237,11525 d ago
Sep 15, 2025TYRA
Tyra Biosciences, Inc.
AGrant or award
Common Stock
+701$9.13$6,39914,788Sep 17, 2025
Aug 7, 2025TYRA
Tyra Biosciences, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+170,000$0.00$0170,000Aug 7, 2025
Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DDisposition to issuer
Common Stock
-24,727--0Jul 2, 2025
Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-29,983--0Jul 2, 2025
Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-7,464--0Jul 2, 2025
Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-15,318--0Jul 2, 2025
Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-13,774--0Jul 2, 2025
Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-12,216--0Jul 2, 2025
May 14, 2025SWTX
SpringWorks Therapeutics, Inc.
AGrant or award
Common Stock
+10,060$0.00$024,727May 15, 2025
Mar 14, 2025TYRA
Tyra Biosciences, Inc.
AGrant or award
Common Stock
+1,238$9.78$12k14,087Mar 18, 2025
Oct 30, 2024TYRA
Tyra Biosciences, Inc.
POpen-market purchase
Common Stock
+9,500$16.00$152k12,849Nov 1, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Alan Fuhrman: insider trades and track record | InsiderTell